Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. Stock
  3. AVAH
AVAH logo

AVAH Overview

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

Loading chart...

High
8.038
Open
7.780
VWAP
7.80
Vol
3.58M
Mkt Cap
1.68B
Low
7.640
Amount
27.88M
EV/EBITDA(TTM)
10.12
Total Shares
217.76M
EV
2.95B
EV/OCF(TTM)
21.28
P/S(TTM)
0.67
Aveanna Healthcare Holdings Inc. is a provider of diversified home care platforms. The Company's segments include Private Duty Services (PDS), Home Health & Hospice (HHH), and Medical Solutions (MS). The PDS segment includes private duty nursing (PDN) services, as well as pediatric therapy services. The HHH segment includes home health services, as well as hospice and specialty program services. Its home health services involve the provision of in-home services to its patients by its clinicians, which include nurses, therapists, social workers and home health aides. Its hospice services involve a supportive philosophy and concept of care for those nearing the end of life. The Medical Solutions segment offers a line of enteral nutrition supplies and other products to adults and children, delivered on a periodic or as-needed basis. The MS business serves patients who have short or long-term disabilities and require a supply of infant, pediatric and adult formulas.
Show More

Events Timeline

(ET)
2026-05-14
07:10:00
Aveanna Reports Q1 Revenue of $647.92M, Beating Expectations
select
2026-05-14
07:10:00
Company Raises FY26 Adjusted EBITDA Outlook to $328M-$332M
select
2026-05-13 (ET)
2026-05-13
10:00:00
CMS Implements Six-Month Moratorium on New Medicare Enrollment
select
link

News

seekingalpha
9.5
05-14seekingalpha
PinnedAveanna Healthcare Q1 2026 Earnings Highlights
  • Significant Revenue Growth: Aveanna Healthcare reported approximately $648 million in revenue for Q1 2026, representing a 15.9% year-over-year increase, primarily driven by improved rates and volume, indicating strong growth potential in the healthcare services sector.
  • Adjusted EBITDA Performance: The adjusted EBITDA for the first quarter was $84.4 million, reflecting the company's ongoing efforts to enhance operational efficiencies, which are expected to further drive profitability and competitive positioning in the market.
  • Increase in Preferred Payer Agreements: The company signed four preferred payer agreements in Q1, raising the share of preferred payers in Private Duty Services from 57% to 60%, which will help improve service quality and customer satisfaction, thereby solidifying market position.
  • Upward Revision of Full-Year Outlook: Aveanna raised its full-year revenue guidance for 2026 to a range of $2.56 billion to $2.58 billion, with adjusted EBITDA expectations of $328 million to $332 million, demonstrating management's confidence in future performance, despite excluding the upcoming Family First acquisition.
CNBC
6.0
05-15CNBC
Wall Street's Latest Upgrade Calls Overview
  • RXO Upgrade: Stifel upgraded RXO from hold to buy, citing a favorable market setup emerging into the latter half of 2026, particularly at the intersection of improving brokerage fundamentals and unique idiosyncratic levers, indicating potential growth opportunities.
  • Cisco Rating Boost: HSBC upgraded Cisco to buy from hold following the company's recent earnings report, raising the price target from $77 to $137, reflecting strong momentum in AI infrastructure and improved earnings visibility.
  • Arista Networks Upgrade: Raymond James upgraded Arista Networks from market perform to outperform, anticipating improved sales growth in 2027 and beyond, particularly as the company expands into AI backend and campus applications, enhancing its market share.
  • Dell Reiteration: Morgan Stanley reiterated its overweight rating on Dell, raising the price target from $205 to $280, expecting the company to raise its FY27 earnings guidance again, although supply visibility still needs to catch up with the high demand outlook for AI servers.
Yahoo Finance
4.5
05-14Yahoo Finance
Healthcare Stocks Mixed in Premarket Trading
  • Market Performance: Healthcare stocks exhibited mixed results in premarket trading on Thursday, indicating divergent market sentiments that may be influenced by upcoming economic data releases.
  • Investor Focus: Despite the mixed performance, investors are closely monitoring developments in the healthcare sector, particularly in light of changing policies and market trends that could impact future investment decisions.
  • Industry Volatility: The volatility in healthcare stocks reflects the market's sensitivity to economic recovery and healthcare policy changes, prompting investors to carefully assess risks and opportunities.
  • Future Outlook: As economic data is released, the performance of healthcare stocks may be further influenced, necessitating investors to stay informed and adjust their strategies accordingly.
seekingalpha
9.5
05-14seekingalpha
Aveanna Healthcare Holdings Raises 2026 Revenue Guidance Amid Strong Q1 Results
  • Strong Earnings Beat: Aveanna Healthcare Holdings reported a Q1 non-GAAP EPS of $0.18, exceeding expectations by $0.05, which reflects the company's robust performance in the healthcare sector and boosts investor confidence.
  • Significant Revenue Growth: The company achieved Q1 revenue of $647.9 million, marking a 15.9% year-over-year increase and surpassing market expectations by $34.66 million, indicating sustained competitiveness and driving overall business growth.
  • Increased 2026 Revenue Guidance: Aveanna raised its 2026 revenue guidance to between $2.56 billion and $2.58 billion, up from the previous range of $2.54 billion to $2.56 billion, reflecting management's optimistic outlook for future performance.
  • Adjusted EBITDA Guidance Upgraded: The adjusted EBITDA guidance for 2026 was also increased to between $328 million and $332 million, up from the prior range of $318 million to $322 million, demonstrating improved profitability and operational efficiency.
seekingalpha
9.5
05-13seekingalpha
Aveanna Healthcare to Announce Q1 Earnings on May 14
  • Earnings Announcement: Aveanna Healthcare Holdings (AVAH) is set to release its Q1 2023 earnings on May 14 before market open, with consensus EPS estimate at $0.13, reflecting a significant year-over-year increase of 333.3%, and a revenue estimate of $613.24 million, up 9.7% year-over-year.
  • Performance Exceeding Expectations: Over the past year, Aveanna has consistently beaten EPS and revenue estimates 100% of the time, showcasing its robust profitability and market adaptability, which bolsters investor confidence.
  • Expectation Revision Dynamics: In the last three months, EPS estimates have undergone three upward revisions and two downward adjustments, while revenue estimates have seen three upward and three downward revisions, indicating market divergence and uncertainty regarding the company's future performance.
  • Long-term Growth Targets: Aveanna has set a revenue target of $2.54 billion to $2.56 billion for 2026 and plans to establish eight new preferred payer agreements, demonstrating its proactive strategic positioning to expand market share and enhance revenue streams.
Newsfilter
1.0
05-12Newsfilter
Aveanna Healthcare to Attend Investor Conference
  • Investor Conference Schedule: Aveanna Healthcare will present at the William Blair 46th Annual Growth Stock Conference in Chicago on June 2, 2026, at 2:40 PM CST, aiming to attract potential investors and enhance company visibility.
  • Webcast Accessibility: The conference will feature a simultaneous webcast, allowing investors to listen in via the company's Investor Relations section on its website, ensuring that those unable to attend in person can still access the latest company updates and enhance transparency.
  • Wide Range of Services: Aveanna operates in 38 states, providing various healthcare services including nursing, rehabilitation, and therapy services, designed to offer high-quality, lower-cost alternatives to prolonged hospitalization, thereby solidifying its market position.
  • Case Management Services: The company also offers case management services to assist families and patients in coordinating resources among insurers, physicians, and hospitals, improving service efficiency and meeting personalized patient needs, which enhances customer satisfaction.
Wall Street analysts forecast AVAH stock price to rise
5 Analyst Rating
Wall Street analysts forecast AVAH stock price to rise
3 Buy
2 Hold
0 Sell
Moderate Buy
Current: 0.000
sliders
Low
10.00
Averages
10.75
High
11.00
Current: 0.000
sliders
Low
10.00
Averages
10.75
High
11.00
RBC Capital
Ben Hendrix
Sector Perform
maintain
$9 -> $10
AI Analysis
2026-05-15
New
Reason
RBC Capital
Ben Hendrix
Price Target
$9 -> $10
AI Analysis
2026-05-15
New
maintain
Sector Perform
Reason
RBC Capital analyst Ben Hendrix raised the firm's price target on Aveanna to $10 from $9 and keeps a Sector Perform rating on the shares. The company delivered a strong Q1 beat and raise, with adjusted EBITDA exceeding the firm's estimate and consensus by a strong margin even excluding a one-time benefit from bad debt reversals, the analyst tells investors in a research note. The management also sees no disruption on the horizon from the administration's new home health moratorium, RBC added.
Stephens
Scott Fidel
Equal Weight -> Overweight
upgrade
$10 -> $11
2026-05-15
New
Reason
Stephens
Scott Fidel
Price Target
$10 -> $11
2026-05-15
New
upgrade
Equal Weight -> Overweight
Reason
As previously reported, Stephens analyst Scott Fidel upgraded Aveanna to Overweight from Equal Weight with a price target of $11, up from $10. Aveanna has delivered a \"sustained cadence of beat-and-raise quarters\" with a 2026 outlook that is continuing that momentum, the analyst tells investors. The risk/reward is \"attractive\" at the current valuation, the analyst added.
Unlock Full Analyst Thesis, Get the complete breakdown of rating reason for AVAH
Unlock Now

Valuation Metrics

The current forward P/E ratio for Aveanna Healthcare Holdings Inc (AVAH.O) is 10.54, compared to its 5-year average forward P/E of 38.12. For a more detailed relative valuation and DCF analysis to assess Aveanna Healthcare Holdings Inc's fair value, Click here.

Forward PE

The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average PE
38.12
Current PE
10.54
Overvalued PE
140.76
Undervalued PE
-64.52

Forward EV/EBITDA

The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
5Y Average EV/EBITDA
12.18
Current EV/EBITDA
9.37
Overvalued EV/EBITDA
13.99
Undervalued EV/EBITDA
10.37

Forward PS

The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
5Y Average PS
0.42
Current PS
0.62
Overvalued PS
0.70
Undervalued PS
0.15

Financials

AI Analysis
Annual
Quarterly

Related Community Screener

best stock for swing traders tomorrow
Intellectia · 75 candidates
Price: $5.00 - $100.00Rsi Category: moderateList Exchange: XNYS, XNAS, XASEMoving Average Relationship: PriceCrossAboveMA20One Day Rise Prob: >= 60Monthly Average Dollar Volume: >= 1,000,000
Ticker
Name
Market Cap$
top bottom
DNLI logo
DNLI
Denali Therapeutics Inc
3.15B
MITK logo
MITK
Mitek Systems Inc
647.57M
SXC logo
SXC
SunCoke Energy Inc
552.33M
RDWR logo
RDWR
Radware Ltd
1.10B
DHT logo
DHT
DHT Holdings Inc
2.91B
PHVS logo
PHVS
Pharvaris NV
1.87B

Whales Holding AVAH

J
Jaunty Global Limited
Holding
AVAH
+6.33%
3M Return

Trading Trends

    Insider
    Hedge Fund
    Congress Trading

People Also Watch

Frequently Asked Questions

What is Aveanna Healthcare Holdings Inc (AVAH) stock price today?

The current price of AVAH is 7.72 USD — it has increased 3.76

What is Aveanna Healthcare Holdings Inc (AVAH)'s business?

Aveanna Healthcare Holdings Inc. is a provider of diversified home care platforms. The Company's segments include Private Duty Services (PDS), Home Health & Hospice (HHH), and Medical Solutions (MS). The PDS segment includes private duty nursing (PDN) services, as well as pediatric therapy services. The HHH segment includes home health services, as well as hospice and specialty program services. Its home health services involve the provision of in-home services to its patients by its clinicians, which include nurses, therapists, social workers and home health aides. Its hospice services involve a supportive philosophy and concept of care for those nearing the end of life. The Medical Solutions segment offers a line of enteral nutrition supplies and other products to adults and children, delivered on a periodic or as-needed basis. The MS business serves patients who have short or long-term disabilities and require a supply of infant, pediatric and adult formulas.

What is the price predicton of AVAH Stock?

Wall Street analysts forecast AVAH stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for AVAH is10.75 USD with a low forecast of 10.00 USD and a high forecast of 11.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

What is Aveanna Healthcare Holdings Inc (AVAH)'s revenue for the last quarter?

Aveanna Healthcare Holdings Inc revenue for the last quarter amounts to 647.91M USD, increased 15.86

What is Aveanna Healthcare Holdings Inc (AVAH)'s earnings per share (EPS) for the last quarter?

Aveanna Healthcare Holdings Inc. EPS for the last quarter amounts to 0.19 USD, increased 533.33

How many employees does Aveanna Healthcare Holdings Inc (AVAH). have?

Aveanna Healthcare Holdings Inc (AVAH) has 3500 emplpoyees as of May 16 2026.

What is Aveanna Healthcare Holdings Inc (AVAH) market cap?

Today AVAH has the market capitalization of 1.68B USD.